Study of factors associated with fatty acid in the blood of hemodialysis patients :cross-sectional study and cross-over study with EPA ethyl ester.

Study of factors associated with fatty acid in the blood of hemodialysis patients :cross-sectional study and cross-over study with EPA ethyl ester. - Study of factors associated with fatty acid in the blood of hemodialysis patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006806

Enrollment

150

Registered

2011-11-30

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maintenance hemodialysis patients

Interventions

EPA ethyl ester (+) to EPA ethyl ester (-) EPA ethyl ester (-) to EPA ethyl ester (+)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Maintenance hemodialysis patients

Exclusion criteria

Exclusion criteria: 1) Pts who meet the contraindiation criteria in package insert of EPA ethyl ester 2) Pregnant or possibly pregnant pts, pts on lactation 3) Inappropriate pts for this study according to the investigator's judgment 4) The patients who do not agree with this study

Design outcomes

Primary

Measure	Time frame
1. EPA/AA ratio 2. hs-CRP in blood 3. back ground of patients, risk factors of CVD	—

Secondary

Measure	Time frame
1. ADMA in blood 2. AGEs in blood 3. ABI, IMT	—

Countries

Japan

Contacts

Public ContactHiroko Inagaki

Chiyoda Hospital Internal medicine, dialysis

0982-52-7111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026